Tirzepatide

Tirzepatide – Available in Multiple Research Dosages (Lyophilized Powder) – For Research Use Only

Tirzepatide is a synthetic dual-receptor agonist targeting both the GLP-1 and GIP receptors. It is a leading next-generation compound in metabolic and weight research.

Research models have examined Tirzepatide for its combined incretin activity, studying effects on glucose regulation, appetite signaling, and metabolic homeostasis.

Product Details:

• Peptide: Tirzepatide (GLP-1 / GIP dual agonist)
• Purity: ≥99%
• Form: Lyophilized powder
• Quantity: Available in multiple research dosages (select on product page)
• Store lyophilized at -20°C (-4°F). After reconstitution, refrigerate at 2–8°C (36–46°F) and use within 30 days.
• Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.

Potential Research Applications:

• Glucose-regulation and metabolic studies
• Appetite-signaling and weight-research models
• Dual-incretin (GLP-1/GIP) receptor research

Product must be reconstituted.

For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.

THIS IS NOT FOR HUMAN CONSUMPTION. SOLD FOR RESEARCH ONLY.